ZTTK Syndrome: Clinical and Molecular Findings Of 15 Cases and a Review of the Literature

Zhu-Tokita-Takenouchi-Kim (ZTTK) syndrome is caused by de novo loss-of-function variants in the SON gene (MIM #617140). This multisystemic disorder is characterized by intellectual disability, seizures, abnormal brain imaging, variable dysmorphic features, and various congenital anomalies. The wide application and increasing accessibility of whole exome sequencing (WES) has helped to identify new cases of ZTTK syndrome over the last few years. To date, there have been approximately 45 cases reported in the literature. Here, we describe 15 additional individuals with variants in the SON gene, including those with missense variants bringing the total number of known cases to 60. We have reviewed the clinical and molecular data of these new cases and all previously reported cases to further delineate the most common as well as emerging clinical findings related to this syndrome. Furthermore, we aim to delineate any genotype-phenotype correlations specifically for a recurring pathogenic four base pair deletion (c.5753_5756del) along with discussing the impact of missense variants seen in the SON gene.

Citing Articles

Recurrent myocardial injury in a de novo SON mutation ZTTK syndrome patient: a case report.

Na J, Cui L, Zhen Z, Chen X, Li Q, Gao L BMC Pediatr. 2024; 24(1):232.

PMID: 38566089 PMC: 10985872. DOI: 10.1186/s12887-024-04703-4.

Optical Genome Mapping as a Potential Routine Clinical Diagnostic Method.

Barseghyan H, Eisenreich D, Lindt E, Wendlandt M, Scharf F, Benet-Pages A Genes (Basel). 2024; 15(3).

PMID: 38540401 PMC: 10970541. DOI: 10.3390/genes15030342.

Expanding the mutational spectrum of ZTTK syndrome: A de novo variant with global developmental delay and malnutrition in a Chinese patient.

Tang S, You J, Liu L, OuYang H, Jiang N, Duan J Mol Genet Genomic Med. 2023; 11(8):e2188.

PMID: 37488749 PMC: 10422072. DOI: 10.1002/mgg3.2188.

Case report: A novel SON mutation in a Colombian patient with ZTTK syndrome.

Vasquez-Forero D, Masotto B, Ferrer-Avargues R, Moya C, Pachajoa H Front Genet. 2023; 14:1183362.

PMID: 37476413 PMC: 10354630. DOI: 10.3389/fgene.2023.1183362.

Metabolic Stroke as a Clinical Manifestation of Zhu-Tokita-Takenouchi-Kim Syndrome: A Case Series.

El-Said A, Morales J, Rossi G, Longani N Neurol Genet. 2023; 9(3):e200072.

PMID: 37168776 PMC: 10166595. DOI: 10.1212/NXG.0000000000200072.

References

Slezak R, Smigiel R, Rydzanicz M, Pollak A, Kosinska J, Stawinski P . Phenotypic expansion in Zhu-Tokita-Takenouchi-Kim syndrome caused by de novo variants in the SON gene. Mol Genet Genomic Med. 2020; 8(10):e1432. PMC: 7549597. DOI: 10.1002/mgg3.1432. View

Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

Zhu X, Petrovski S, Xie P, Ruzzo E, Lu Y, McSweeney K . Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med. 2015; 17(10):774-81. PMC: 4791490. DOI: 10.1038/gim.2014.191. View

Yang Y, Xu L, Yu Z, Huang H, Yang L . Clinical and genetic analysis of ZTTK syndrome caused by SON heterozygous mutation c.394C>T. Mol Genet Genomic Med. 2019; 7(11):e953. PMC: 6825855. DOI: 10.1002/mgg3.953. View

Ahn E, DeKelver R, Lo M, Nguyen T, Matsuura S, Boyapati A . SON controls cell-cycle progression by coordinated regulation of RNA splicing. Mol Cell. 2011; 42(2):185-98. PMC: 3137374. DOI: 10.1016/j.molcel.2011.03.014. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Tan Y, Duan L, Yang K, Liu Q, Wang J, Dong Z . A novel frameshift variant in SON causes Zhu-Tokita-Takenouchi-Kim Syndrome. J Clin Lab Anal. 2020; 34(8):e23326. PMC: 7439338. DOI: 10.1002/jcla.23326. View

Ueda M, Matsuki T, Fukada M, Eda S, Toya A, Iio A . Knockdown of Son, a mouse homologue of the ZTTK syndrome gene, causes neuronal migration defects and dendritic spine abnormalities. Mol Brain. 2020; 13(1):80. PMC: 7245844. DOI: 10.1186/s13041-020-00622-4. View

Tokita M, Braxton A, Shao Y, Lewis A, Vincent M, Kury S . De Novo Truncating Variants in SON Cause Intellectual Disability, Congenital Malformations, and Failure to Thrive. Am J Hum Genet. 2016; 99(3):720-727. PMC: 5011061. DOI: 10.1016/j.ajhg.2016.06.035. View

10.

Kim J, Shinde D, Reijnders M, Hauser N, Belmonte R, Wilson G . De Novo Mutations in SON Disrupt RNA Splicing of Genes Essential for Brain Development and Metabolism, Causing an Intellectual-Disability Syndrome. Am J Hum Genet. 2016; 99(3):711-719. PMC: 5011044. DOI: 10.1016/j.ajhg.2016.06.029. View

11.

Quintana Castanedo L, Sanchez Orta A, Maseda Pedrero R, Santos Simarro F, Palomares Bralo M, Feito Rodriguez M . Skin and nails abnormalities in a patient with ZTTK syndrome and a de novo mutation in SON. Pediatr Dermatol. 2020; 37(3):517-519. DOI: 10.1111/pde.14113. View

12.

Takenouchi T, Miura K, Uehara T, Mizuno S, Kosaki K . Establishing SON in 21q22.11 as a cause a new syndromic form of intellectual disability: Possible contribution to Braddock-Carey syndrome phenotype. Am J Med Genet A. 2016; 170(10):2587-90. DOI: 10.1002/ajmg.a.37761. View

13.

Yang L, Yang F . A de novo heterozygous variant in the SON gene is associated with Zhu-Tokita-Takenouchi-Kim syndrome. Mol Genet Genomic Med. 2020; 8(11):e1496. PMC: 7667370. DOI: 10.1002/mgg3.1496. View

14.

Kim J, Park E, Chitayat D, Stachura D, Schaper J, Lindstrom K . SON haploinsufficiency causes impaired pre-mRNA splicing of CAKUT genes and heterogeneous renal phenotypes. Kidney Int. 2019; 95(6):1494-1504. PMC: 6534475. DOI: 10.1016/j.kint.2019.01.025. View

15.

Kim J, Baddoo M, Park E, Stone J, Park H, Butler T . SON and Its Alternatively Spliced Isoforms Control MLL Complex-Mediated H3K4me3 and Transcription of Leukemia-Associated Genes. Mol Cell. 2016; 61(6):859-73. PMC: 4799497. DOI: 10.1016/j.molcel.2016.02.024. View